More

    Finance

    US VP Harris announces $1.5 billion in Ukraine aid at Switzerland peace summit By Reuters

    By Steve Holland LUCERNE, Switzerland (Reuters) -U.S. Vice President Kamala Harris pledged America's unwavering support for Ukraine and announced more than $1.5...

    CEO succession: Bank slaps ‘golden handcuffs’ on 2 execs

    Citizens Financial Group just slapped a pair of “golden handcuffs” on two executives who might someday lead the bank. The 14th-largest bank with $222...

    We live in a 940-sq-ft trailer in Laguna Beach: Take a look inside

    When my husband Brian first told me he's from Laguna Beach, it took everything in me to play it cool. "Oh, is that...

    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lamb Weston Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action “ LW

    NEW YORK, June 15, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of...

    2 unusual tips to get the most nutrients from immunity-boosting foods

    Experts say you should aim to bolster your immune system no matter the season, and diet is a major way you can do...

    Brazil’s Lula stands by finance minister but rejects spending cuts targeting the poor By Reuters

    (Reuters) - Brazil's President Luiz Inacio Lula da Silva said on Saturday he is open to analyzing Finance Minister Fernando Haddad's spending...

    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages 2U, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action “ TWOU

    NEW YORK, June 15, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of...

    INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class...

    SAN DIEGO, June 15, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the GoodRx class action lawsuit seeks to...

    Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid...

    “ ENERGIZE is the First Study to Demonstrate Efficacy of an Oral Treatment for  Non-Transfusion-Dependent Alpha- and Beta-Thalassemia “ “ Additional ENERGIZE Poster...

    Latest articles

    spot_imgspot_img